Development of novel methods for periplasmic release of biotherapeutic products
The production of biotherapeutics including antibodies and antibody fragments is a rapidly expanding market with an increasing number of products being approved for use. One of the major platforms used for production of such therapeutics is Escherichia coli, which offers a rapid production at low pr...
| Main Author: | |
|---|---|
| Published: |
University of Birmingham
2017
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.720714 |